Compare Diagnos Laboratorium Utama Tbk. (DGNS) vs Sarana Meditama Metropolitan Tbk. (SAME) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Diagnos Laboratorium Utama Tbk. vs Sarana Meditama Metropolitan Tbk. — how do they compare? Diagnos Laboratorium Utama Tbk. trades at Rp230 (market cap 321.75B, 152.8K 24h volume), while Sarana Meditama Metropolitan Tbk. trades at Rp296 (market cap 5.15T, 335.5K 24h volume). The key difference: Sarana Meditama Metropolitan Tbk. is far larger — about 16× Diagnos Laboratorium Utama Tbk.'s market cap, and Sarana Meditama Metropolitan Tbk. is more actively traded (335.5K versus 152.8K). Which is the better fit depends on your goals.
| DGNS | SAME | |
|---|---|---|
Market Cap | 321.75B | 5.15T |
Volume | 152.8K | 335.5K |
Lot | 1.53K | 3.36K |
Turnover | 35.37M | 99.9M |
Average Price | 231.49 | 297.77 |
Value | 35.37M | 99.9M |
Indicative Equilibrium Price | 230 | 296 |
Indicative Equilibrium Volume | 1 | 275 |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Diagnos Laboratorium Utama Tbk.
PT Diagnos Laboratorium Utama Tbk (the “Company”) was established in the Republic of Indonesia on August 29, 2007 under framework of the Domestic Capital Investment Law No. 6 Year 1968 based on Deed No.17 dated August 29, 2007, of Martinef, S.H., M.Si., Notary in Bekasi. The Company started its commercial operation in 2008.
Read more on DGNS →About Sarana Meditama Metropolitan Tbk.
PT Sarana Meditama Metropolitan (the Company) was established based on Notarial Deed No. 27 of Budiarti Karnadi, S.H., dated November 13, 1984
Read more on SAME →
